Research studies

Research studies

Patient recruitment and data collection is ongoing
2013-2017

LLDAS Validation Study

First multi-national, prospective, validation study of Lupus Low Disease Activity State (LLDAS) as a treat-to-target (T2T) endpoint, demonstrating that LLDAS attainment provides significant protection from organ damage accrual and flare in patients with systemic lupus erythematosus (SLE).

2018-2022

T2T -SLE Study

Extension and expansion of LLDAS validation study aimed to capture longer follow up data and more patient recruitment to further examine LLDAS and remission definitions.

2022-2026  

Outcomes in SLE

Planned future study. Watch this space!